These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 550692)
1. A new and sensitive method for quantifying and comparing the biological potency of varius estrogens in man. Damber MG; Sandström B; von Schoultz B; Stigbrand T Acta Obstet Gynecol Scand; 1979; 58(6):527-30. PubMed ID: 550692 [TBL] [Abstract][Full Text] [Related]
2. Estrogenic potency of oral replacement therapy estimated by the induction of pregnancy zone protein. Helgason S; Damber MG; von Schoultz B; Stigbrand T Acta Obstet Gynecol Scand; 1982; 61(1):75-9. PubMed ID: 6283781 [TBL] [Abstract][Full Text] [Related]
3. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects. Helgason S Acta Obstet Gynecol Scand Suppl; 1982; 107():1-29. PubMed ID: 6282033 [TBL] [Abstract][Full Text] [Related]
4. The effect of various regimens of hormone therapy on serum cholesterol and triglyceride concentrations in postmenopausal women. Paterson ME; Sturdee DW; Moore B; Whitehead TP Br J Obstet Gynaecol; 1980 Jul; 87(7):552-60. PubMed ID: 6252948 [TBL] [Abstract][Full Text] [Related]
5. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate. Furuhjelm M; Carlström K Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703 [TBL] [Abstract][Full Text] [Related]
6. The influence of short-term estrogen replacement therapy (ERT) on the blood pressure and daily urinary catecholamine excretion in a small group of post-menopausal women. Blum M; Assa S; Bacalu B; Honig B; Blum I Eur J Obstet Gynecol Reprod Biol; 1986 Nov; 23(3-4):195-9. PubMed ID: 3817261 [TBL] [Abstract][Full Text] [Related]
7. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW; de la Peña A; Chenault CB; Cervantes A Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928 [TBL] [Abstract][Full Text] [Related]
8. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject]. Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543 [TBL] [Abstract][Full Text] [Related]
9. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796 [TBL] [Abstract][Full Text] [Related]
10. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin. Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063 [TBL] [Abstract][Full Text] [Related]
11. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785 [TBL] [Abstract][Full Text] [Related]
12. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation. Bostofte E; Hemmingsen L; Møller KJ; Serup J; Weber T Acta Endocrinol (Copenh); 1978 Apr; 87(4):855-64. PubMed ID: 347855 [TBL] [Abstract][Full Text] [Related]
13. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception. Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512 [TBL] [Abstract][Full Text] [Related]
14. [Changes in plasma binding protein of sex steroids and transcortin during the treatment of menopause with oral estrogens]. Pugeat M; Lejeune H; Mazenod B; Dechaud H; Fleury MC; Tourniaire J Presse Med; 1988 Jun; 17(23):1189-92. PubMed ID: 2969549 [TBL] [Abstract][Full Text] [Related]
15. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Rosenfeld WE; Doose DR; Walker SA; Nayak RK Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594 [TBL] [Abstract][Full Text] [Related]
16. Changes in plasma renin concentration, activity and substrate after twentyeight days' treatment with micronized estrogen, ethinylestradiol and norethisterone-acetate in postmenopausal women. Brøns M; Jacobsen JG; Kristoffersen K Acta Med Scand Suppl; 1981; 646():94-7. PubMed ID: 7018189 [No Abstract] [Full Text] [Related]
17. Norethindrone in serum after use of an oral contraceptive containing norethindrone acetate. Sarkar NN; Laumas V; Agarwal N; Hingorani V; Laumas KR Acta Obstet Gynecol Scand; 1983; 62(1):71-6. PubMed ID: 6858629 [TBL] [Abstract][Full Text] [Related]
18. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy. Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A Popul Sci; 1982; (3):157-68. PubMed ID: 12266214 [TBL] [Abstract][Full Text] [Related]
19. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related]
20. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol. Odlind V; Weiner E; Victor A; Johansson ED Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]